Buscar resultados de ensayos clínicos
Carcinoma, Islet Cell - 25 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors Condición:
Fecha: 2007-01-29 Intervenciones:
|
Recruiting |
Nombre del estudio: Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II Condición: Pancreatic Neuroendocrine Carcinoma Fecha: 2014-08-27 Intervenciones:
|
Completed |
Nombre del estudio: RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma Condición:
Fecha: 2005-06-07 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condición:
|
Withdrawn |
Nombre del estudio: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors Condición:
Intervenciones:
|
Completed |
Nombre del estudio: A Study of IMC-A12 in Islet Cell Cancer Condición:
Fecha: 2008-10-27 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery Condición:
|
Recruiting |
Nombre del estudio: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery Condición:
Fecha: 1999-11-03 Intervenciones: Drug: Interferon |
Recruiting |
Nombre del estudio: Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Condición:
|